IDEXX Laboratories, Inc.

IDXX Healthcare Diagnostics & Research

IDEXX Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 10.4% from fiscal 2024. In the quarter to June 2026, revenue grew 9.66%, EPS grew 17.2%, free cash flow grew 111.4% and total debt fell 14.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years, operating cash flow growth for three.

560.36 13.18 +2.41%
Market cap
$43.1B
P/E
39.1×
Fwd P/E
38.3×
Dividend yield
—
F-score
8/9
Altman Z
24.09
Beneish M
−2.50
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
47.42 52.60 42.96 52.65 73.40 75.34 50.00 53.85 38.39 51.33
Piotroski F-Score
7 9 8 8 7 8 5 8 6 8
P/S ratio
5.94 7.03 7.30 9.34 15.76 17.45 10.08 12.43 8.75 12.64
Altman Z-Score
6.19 7.24 9.74 11.65 19.16 23.62 13.66 19.92 16.75 24.09
P/FCF ratio
38.49 46.70 58.79 75.78 78.94 88.83 88.38 59.64 47.28 56.88
Altman Z″-Score (non-manufacturers)
2.24 2.99 4.12 4.82 6.90 7.41 6.45 8.68 9.23 10.43
Beneish M-Score
(2.76) (2.64) (2.31) (2.37) (2.42) (2.29) (2.22) (2.38) (2.48) (2.50)
P/Operating CF
104.73 114.35 119.12 144.69 194.85 267.19 195.77 182.09 130.12 152.94
P/B ratio
0.00 0.00 0.00 126.46 67.42 81.31 55.77 30.65 21.37 33.89
EV/Sales
6.06 7.10 7.52 9.72 15.95 17.67 10.28 12.49 8.83 12.71
EV/EBITDA
25.05 28.19 28.96 36.51 54.63 54.80 34.24 37.74 27.36 36.33
EV/FCF
39.23 47.16 60.54 78.85 79.91 89.94 90.09 59.95 47.74 57.16
Current Ratio
0.90 0.97 0.85 0.94 1.82 1.25 0.89 1.57 1.31 1.23
Net Debt/EBITDA
1.89 1.59 1.53 1.42 0.66 0.68 0.65 0.20 0.26 0.18
Debt/Equity
(11.13) (23.42) (108.34) 5.64 1.44 1.23 1.26 0.47 0.39 0.28
ROE
(231.05%) (324.76%) (1,195.50%) 507.40% 143.54% 112.62% 104.58% 80.74% 57.66% 66.20%
ROA
14.77% 16.22% 23.20% 25.39% 28.19% 31.48% 26.20% 28.14% 27.10% 31.89%
ROIC
31.09% 35.11% 35.41% 31.69% 37.51% 41.74% 44.39% 39.67% 36.64% 45.33%
Return on Tangible Assets
82.72% 75.94% 117.46% 87.62% 56.20% 95.52% 131.82% 67.83% 84.95% 104.65%
Average Days of Receivables
42.04 43.49 41.04 40.84 44.69 41.81 43.43 45.61 44.35 46.85
Earnings Yield
2.11% 1.90% 2.33% 1.90% 1.36% 1.33% 2.00% 1.86% 2.60% 1.95%
Free Cash Flow Yield
2.60% 2.14% 1.70% 1.32% 1.27% 1.13% 1.13% 1.68% 2.11% 1.76%
Free Cash Flow per Share
3.06 3.38 3.19 3.53 6.33 7.46 4.59 9.30 9.68 12.98
Book value per Share
(1.21) (0.61) (0.11) 2.07 7.41 8.10 7.28 17.87 19.34 19.96
Free Cash Flow
274.16 296.57 277.15 303.93 540.44 636.00 384.15 772.88 798.08 1,043.58
EV/EBIT
30.71 33.86 33.86 42.33 62.18 60.95 38.51 41.69 30.51 40.21
Other line items

Show all line items

Columns are period end dates